Skip to main content
. 2023 Aug 9;22(9):100630. doi: 10.1016/j.mcpro.2023.100630

Fig. 3.

Fig. 3

Analysis of2mM Na-ATP treatmentdata from Sridharan etal.using design of experiment (DOE). (A), percent of total “All Others” and ATP-binding proteins as a function of the R2 used as criteria for selection of proteins of interest. B, percent of total “All Others” and ATP-binding proteins as a function of melt shift p-value criteria with inset showing 0 to 0.05. C, percent of total “All Others” and ATP-binding proteins as a function of melt shift p-value and the number of unique peptides. Analysis of 1 mM dasatinib treatment data from Kalxdorf et.al. D, percent of total nonkinase and kinase activity proteins as a function of the R2 used as criteria for selection of proteins of interest. E, percent of total nonkinase and kinase activity proteins as a function of melt shift p-value criteria with inset showing 0 to 0.05. F, percent of total nonkinase and kinase activity proteins as a function of melt shift p-value and the number of unique peptides.